$CUE Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Cue Biopharma, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Cue Biopharma, Inc.. Get notifications about new insider transactions in Cue Biopharma, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 17 2021 | CUE | Cue Biopharma, Inc ... | Pienta Kenneth | Chief Medical Offic ... | Option Exercise | M | 5.00 | 439 | 2,195 | 133,567 | |
Mar 17 2021 | CUE | Cue Biopharma, Inc ... | Pienta Kenneth | Chief Medical Offic ... | Option Exercise | M | 5.00 | 13,000 | 65,000 | 134,006 | |
Mar 17 2021 | CUE | Cue Biopharma, Inc ... | Pienta Kenneth | Chief Medical Offic ... | Sell | S | 15.09 | 439 | 6,626 | 2,000 | 2.4 K to 2 K (-18.00 %) |
Mar 17 2021 | CUE | Cue Biopharma, Inc ... | Pienta Kenneth | Chief Medical Offic ... | Buy | M | 5.00 | 439 | 2,195 | 2,439 | 2 K to 2.4 K (+21.95 %) |
Mar 17 2021 | CUE | Cue Biopharma, Inc ... | Pienta Kenneth | Chief Medical Offic ... | Sell | S | 15.10 | 13,000 | 196,269 | 2,000 | 15 K to 2 K (-86.67 %) |
Mar 17 2021 | CUE | Cue Biopharma, Inc ... | Pienta Kenneth | Chief Medical Offic ... | Buy | M | 5.00 | 13,000 | 65,000 | 15,000 | 2 K to 15 K (+650.00 %) |
Feb 18 2021 | CUE | Cue Biopharma, Inc ... | Pienta Kenneth | Chief Medical Offic ... | Option Exercise | M | 5.00 | 2,994 | 14,970 | 147,006 | |
Feb 18 2021 | CUE | Cue Biopharma, Inc ... | Pienta Kenneth | Chief Medical Offic ... | Option Exercise | M | 2.86 | 1,280 | 3,661 | 0 | |
Feb 18 2021 | CUE | Cue Biopharma, Inc ... | Pienta Kenneth | Chief Medical Offic ... | Option Exercise | M | 2.86 | 16,000 | 45,760 | 1,280 | |
Feb 18 2021 | CUE | Cue Biopharma, Inc ... | Pienta Kenneth | Chief Medical Offic ... | Sell | S | 15.06 | 4,274 | 64,345 | 2,000 | 6.3 K to 2 K (-68.12 %) |
Feb 18 2021 | CUE | Cue Biopharma, Inc ... | Pienta Kenneth | Chief Medical Offic ... | Buy | M | 5.00 | 2,994 | 14,970 | 6,274 | 3.3 K to 6.3 K (+91.28 %) |
Feb 18 2021 | CUE | Cue Biopharma, Inc ... | Pienta Kenneth | Chief Medical Offic ... | Buy | M | 2.86 | 1,280 | 3,661 | 3,280 | 2 K to 3.3 K (+64.00 %) |
Feb 18 2021 | CUE | Cue Biopharma, Inc ... | Pienta Kenneth | Chief Medical Offic ... | Sell | S | 15.15 | 16,000 | 242,422 | 2,000 | 18 K to 2 K (-88.89 %) |
Feb 18 2021 | CUE | Cue Biopharma, Inc ... | Pienta Kenneth | Chief Medical Offic ... | Buy | M | 2.86 | 16,000 | 45,760 | 18,000 | 2 K to 18 K (+800.00 %) |
Feb 12 2021 | CUE | Cue Biopharma, Inc ... | Pienta Kenneth | Chief Medical Offic ... | Option Exercise | A | 15.55 | 50,000 | 777,500 | 50,000 | |
Feb 12 2021 | CUE | Cue Biopharma, Inc ... | Suri Anish | President and CSO | Option Exercise | A | 15.55 | 75,000 | 1,166,250 | 75,000 | |
Feb 12 2021 | CUE | Cue Biopharma, Inc ... | PASSERI DANIEL R | CEO | Option Exercise | A | 15.55 | 85,000 | 1,321,750 | 85,000 | |
Feb 12 2021 | CUE | Cue Biopharma, Inc ... | Sandercock Colin | SVP, General Counse ... | Option Exercise | A | 15.55 | 50,000 | 777,500 | 50,000 | |
Feb 12 2021 | CUE | Cue Biopharma, Inc ... | Millar Kerri-Ann | CFO | Option Exercise | A | 15.55 | 70,000 | 1,088,500 | 70,000 | |
Jan 22 2021 | CUE | Cue Biopharma, Inc ... | Pienta Kenneth | Chief Medical Offic ... | Buy | P | 15.07 | 2,720 | 40,980 | 4,720 | 2 K to 4.7 K (+136.00 %) |
Jan 06 2021 | CUE | Cue Biopharma, Inc ... | Simon Barry J. | Director | Option Exercise | A | 12.36 | 10,000 | 123,600 | 10,000 | |
Jan 06 2021 | CUE | Cue Biopharma, Inc ... | Kiener Peter A | Director | Option Exercise | A | 12.36 | 10,000 | 123,600 | 10,000 | |
Jan 06 2021 | CUE | Cue Biopharma, Inc ... | DRISCOLL FREDERICK W | Director | Option Exercise | A | 12.36 | 10,000 | 123,600 | 10,000 | |
Jan 06 2021 | CUE | Cue Biopharma, Inc ... | Morich Frank | Director | Option Exercise | A | 12.36 | 10,000 | 123,600 | 10,000 | |
Jan 06 2021 | CUE | Cue Biopharma, Inc ... | Fletcher Aaron G.L. | Director | Option Exercise | A | 12.36 | 10,000 | 123,600 | 10,000 | |
Jan 06 2021 | CUE | Cue Biopharma, Inc ... | Gray Cameron | Director | Option Exercise | A | 12.36 | 10,000 | 123,600 | 10,000 | |
Jan 06 2021 | CUE | Cue Biopharma, Inc ... | HOWSON TAMAR D | Director | Option Exercise | A | 12.36 | 10,000 | 123,600 | 10,000 | |
Nov 25 2020 | CUE | Cue Biopharma, Inc ... | Fletcher Aaron G.L. | Director | Buy | P | 12.64 | 6,548 | 82,776 | 165,000 | 158.5 K to 165 K (+4.13 %) |
Oct 06 2020 | CUE | Cue Biopharma, Inc ... | Suri Anish | President and CSO | Option Exercise | M | 0.00 | 33,333 | 0 | 33,334 | |
Oct 06 2020 | CUE | Cue Biopharma, Inc ... | Suri Anish | President and CSO | Payment of Exercise | F | 16.30 | 9,800 | 159,740 | 58,091 | 67.9 K to 58.1 K (-14.43 %) |
Oct 06 2020 | CUE | Cue Biopharma, Inc ... | Suri Anish | President and CSO | Buy | M | 0.00 | 33,333 | 0 | 67,891 | 34.6 K to 67.9 K (+96.46 %) |
Oct 01 2020 | CUE | Cue Biopharma, Inc ... | Gray Cameron | Director | Buy | P | 15.30 | 5,000 | 76,500 | 677,500 | 672.5 K to 677.5 K (+0.74 %) |
Oct 01 2020 | CUE | Cue Biopharma, Inc ... | Gray Cameron | Director | Buy | P | 15.00 | 5,000 | 75,000 | 672,500 | 667.5 K to 672.5 K (+0.75 %) |
Sep 18 2020 | CUE | Cue Biopharma, Inc ... | HOWSON TAMAR D | Director | Option Exercise | A | 17.21 | 50,000 | 860,500 | 50,000 | |
Aug 25 2020 | CUE | Cue Biopharma, Inc ... | Millar Kerri-Ann | CFO | Option Exercise | M | 0.00 | 6,666 | 0 | 13,334 | |
Aug 25 2020 | CUE | Cue Biopharma, Inc ... | Millar Kerri-Ann | CFO | Option Exercise | A | 0.00 | 20,000 | 0 | 20,000 | |
Aug 25 2020 | CUE | Cue Biopharma, Inc ... | Millar Kerri-Ann | CFO | Option Exercise | A | 19.87 | 65,000 | 1,291,550 | 65,000 | |
Aug 25 2020 | CUE | Cue Biopharma, Inc ... | Millar Kerri-Ann | CFO | Payment of Exercise | F | 0.00 | 1,900 | 0 | 5,766 | 7.7 K to 5.8 K (-24.78 %) |
Aug 25 2020 | CUE | Cue Biopharma, Inc ... | Millar Kerri-Ann | CFO | Buy | M | 0.00 | 6,666 | 0 | 7,666 | 1,000 to 7.7 K (+666.60 %) |
Aug 07 2020 | CUE | Cue Biopharma, Inc ... | Sandercock Colin | SVP, General Counse ... | Option Exercise | M | 7.50 | 13,274 | 99,555 | 130,100 | |
Aug 07 2020 | CUE | Cue Biopharma, Inc ... | Sandercock Colin | SVP, General Counse ... | Sell | S | 20.00 | 13,274 | 265,480 | 17,125 | 30.4 K to 17.1 K (-43.67 %) |
Aug 07 2020 | CUE | Cue Biopharma, Inc ... | Sandercock Colin | SVP, General Counse ... | Buy | M | 7.50 | 13,274 | 99,555 | 30,399 | 17.1 K to 30.4 K (+77.51 %) |
Aug 07 2020 | CUE | Cue Biopharma, Inc ... | Suri Anish | President and CSO | Option Exercise | M | 6.42 | 800 | 5,136 | 145,000 | |
Aug 07 2020 | CUE | Cue Biopharma, Inc ... | Suri Anish | President and CSO | Sell | S | 20.01 | 800 | 16,008 | 34,558 | 35.4 K to 34.6 K (-2.26 %) |
Aug 07 2020 | CUE | Cue Biopharma, Inc ... | Suri Anish | President and CSO | Buy | M | 6.42 | 800 | 5,136 | 35,358 | 34.6 K to 35.4 K (+2.31 %) |
Aug 05 2020 | CUE | Cue Biopharma, Inc ... | Sandercock Colin | SVP, General Counse ... | Option Exercise | M | 7.50 | 201 | 1,508 | 143,374 | |
Aug 05 2020 | CUE | Cue Biopharma, Inc ... | Sandercock Colin | SVP, General Counse ... | Option Exercise | M | 7.50 | 6,425 | 48,188 | 143,575 | |
Aug 05 2020 | CUE | Cue Biopharma, Inc ... | Sandercock Colin | SVP, General Counse ... | Sell | S | 20.05 | 201 | 4,030 | 17,125 | 17.3 K to 17.1 K (-1.16 %) |
Aug 05 2020 | CUE | Cue Biopharma, Inc ... | Sandercock Colin | SVP, General Counse ... | Buy | M | 7.50 | 201 | 1,508 | 17,326 | 17.1 K to 17.3 K (+1.17 %) |
Aug 05 2020 | CUE | Cue Biopharma, Inc ... | Sandercock Colin | SVP, General Counse ... | Sell | S | 20.00 | 6,425 | 128,500 | 17,125 | 23.6 K to 17.1 K (-27.28 %) |
Aug 05 2020 | CUE | Cue Biopharma, Inc ... | Sandercock Colin | SVP, General Counse ... | Buy | M | 7.50 | 6,425 | 48,188 | 23,550 | 17.1 K to 23.6 K (+37.52 %) |
Aug 05 2020 | CUE | Cue Biopharma, Inc ... | Sandercock Colin | SVP, General Counse ... | Option Exercise | M | 7.50 | 201 | 1,508 | 143,374 | |
Aug 05 2020 | CUE | Cue Biopharma, Inc ... | Sandercock Colin | SVP, General Counse ... | Option Exercise | M | 7.50 | 6,425 | 48,188 | 143,575 | |
Aug 05 2020 | CUE | Cue Biopharma, Inc ... | Sandercock Colin | SVP, General Counse ... | Sell | S | 20.05 | 201 | 4,030 | 17,125 | 17.3 K to 17.1 K (-1.16 %) |
Aug 05 2020 | CUE | Cue Biopharma, Inc ... | Sandercock Colin | SVP, General Counse ... | Buy | M | 7.50 | 201 | 1,508 | 17,326 | 17.1 K to 17.3 K (+1.17 %) |
Aug 05 2020 | CUE | Cue Biopharma, Inc ... | Sandercock Colin | SVP, General Counse ... | Sell | S | 20.00 | 6,425 | 128,500 | 17,125 | 23.6 K to 17.1 K (-27.28 %) |
Aug 05 2020 | CUE | Cue Biopharma, Inc ... | Sandercock Colin | SVP, General Counse ... | Buy | M | 7.50 | 6,425 | 48,188 | 23,550 | 17.1 K to 23.6 K (+37.52 %) |
Aug 05 2020 | CUE | Cue Biopharma, Inc ... | Suri Anish | President and CSO | Option Exercise | M | 6.42 | 400 | 2,568 | 145,800 | |
Aug 05 2020 | CUE | Cue Biopharma, Inc ... | Suri Anish | President and CSO | Option Exercise | M | 6.42 | 3,800 | 24,396 | 146,200 | |
Aug 05 2020 | CUE | Cue Biopharma, Inc ... | Suri Anish | President and CSO | Option Exercise | M | 8.26 | 2,000 | 16,520 | 18,000 | |
Aug 05 2020 | CUE | Cue Biopharma, Inc ... | Suri Anish | President and CSO | Sell | S | 20.14 | 400 | 8,056 | 34,558 | 35 K to 34.6 K (-1.14 %) |
Aug 05 2020 | CUE | Cue Biopharma, Inc ... | Suri Anish | President and CSO | Buy | M | 6.42 | 400 | 2,568 | 34,958 | 34.6 K to 35 K (+1.16 %) |
Aug 05 2020 | CUE | Cue Biopharma, Inc ... | Suri Anish | President and CSO | Sell | S | 20.01 | 5,800 | 116,058 | 34,558 | 40.4 K to 34.6 K (-14.37 %) |
Aug 05 2020 | CUE | Cue Biopharma, Inc ... | Suri Anish | President and CSO | Buy | M | 6.42 | 3,800 | 24,396 | 40,358 | 36.6 K to 40.4 K (+10.39 %) |
Aug 05 2020 | CUE | Cue Biopharma, Inc ... | Suri Anish | President and CSO | Buy | M | 8.26 | 2,000 | 16,520 | 36,558 | 34.6 K to 36.6 K (+5.79 %) |
Aug 05 2020 | CUE | Cue Biopharma, Inc ... | Suri Anish | President and CSO | Option Exercise | M | 6.42 | 400 | 2,568 | 145,800 | |
Aug 05 2020 | CUE | Cue Biopharma, Inc ... | Suri Anish | President and CSO | Option Exercise | M | 6.42 | 3,800 | 24,396 | 146,200 | |
Aug 05 2020 | CUE | Cue Biopharma, Inc ... | Suri Anish | President and CSO | Option Exercise | M | 8.26 | 2,000 | 16,520 | 18,000 | |
Aug 05 2020 | CUE | Cue Biopharma, Inc ... | Suri Anish | President and CSO | Sell | S | 20.14 | 400 | 8,056 | 34,558 | 35 K to 34.6 K (-1.14 %) |
Aug 05 2020 | CUE | Cue Biopharma, Inc ... | Suri Anish | President and CSO | Buy | M | 6.42 | 400 | 2,568 | 34,958 | 34.6 K to 35 K (+1.16 %) |
Aug 05 2020 | CUE | Cue Biopharma, Inc ... | Suri Anish | President and CSO | Sell | S | 20.01 | 5,800 | 116,058 | 34,558 | 40.4 K to 34.6 K (-14.37 %) |
Aug 05 2020 | CUE | Cue Biopharma, Inc ... | Suri Anish | President and CSO | Buy | M | 6.42 | 3,800 | 24,396 | 40,358 | 36.6 K to 40.4 K (+10.39 %) |
Aug 05 2020 | CUE | Cue Biopharma, Inc ... | Suri Anish | President and CSO | Buy | M | 8.26 | 2,000 | 16,520 | 36,558 | 34.6 K to 36.6 K (+5.79 %) |
Jun 25 2020 | CUE | Cue Biopharma, Inc ... | Fletcher Aaron G.L. | Director | Buy | P | 25.24 | 2,953 | 74,534 | 158,452 | 155.5 K to 158.5 K (+1.90 %) |
Jun 25 2020 | CUE | Cue Biopharma, Inc ... | Fletcher Aaron G.L. | Director | Buy | P | 24.64 | 4,547 | 112,038 | 155,499 | 151 K to 155.5 K (+3.01 %) |
May 12 2020 | CUE | Cue Biopharma, Inc ... | Morich Frank | Director | Option Exercise | A | 27.56 | 1,200 | 33,072 | 1,200 | |
Apr 10 2020 | CUE | Cue Biopharma, Inc ... | Suri Anish | President and CSO | Option Exercise | M | 0.00 | 16,666 | 0 | 100,001 | |
Apr 10 2020 | CUE | Cue Biopharma, Inc ... | Suri Anish | President and CSO | Option Exercise | M | 0.00 | 16,666 | 0 | 100,001 | |
Apr 10 2020 | CUE | Cue Biopharma, Inc ... | Suri Anish | President and CSO | Option Exercise | A | 0.00 | 50,000 | 0 | 116,667 | |
Apr 10 2020 | CUE | Cue Biopharma, Inc ... | Suri Anish | President and CSO | Option Exercise | A | 0.00 | 50,000 | 0 | 116,667 | |
Apr 10 2020 | CUE | Cue Biopharma, Inc ... | Suri Anish | President and CSO | Payment of Exercise | F | 0.00 | 5,354 | 0 | 34,558 | 39.9 K to 34.6 K (-13.41 %) |
Apr 10 2020 | CUE | Cue Biopharma, Inc ... | Suri Anish | President and CSO | Payment of Exercise | F | 0.00 | 5,354 | 0 | 34,558 | 39.9 K to 34.6 K (-13.41 %) |
Apr 10 2020 | CUE | Cue Biopharma, Inc ... | Suri Anish | President and CSO | Buy | M | 0.00 | 16,666 | 0 | 39,912 | 23.2 K to 39.9 K (+71.69 %) |
Apr 10 2020 | CUE | Cue Biopharma, Inc ... | Suri Anish | President and CSO | Buy | M | 0.00 | 16,666 | 0 | 39,912 | 23.2 K to 39.9 K (+71.69 %) |
Mar 26 2020 | CUE | Cue Biopharma, Inc ... | Pienta Kenneth | Chief Medical Offic ... | Option Exercise | A | 14.00 | 100,000 | 1,400,000 | 100,000 | |
Feb 12 2020 | CUE | Cue Biopharma, Inc ... | Sandercock Colin | SVP, General Counse ... | Option Exercise | A | 16.26 | 20,000 | 325,200 | 20,000 | |
Feb 12 2020 | CUE | Cue Biopharma, Inc ... | Sandercock Colin | SVP, General Counse ... | Option Exercise | A | 16.26 | 20,000 | 325,200 | 20,000 | |
Feb 12 2020 | CUE | Cue Biopharma, Inc ... | Millar Kerri-Ann | VP-Finance | Option Exercise | A | 16.26 | 30,000 | 487,800 | 30,000 | |
Feb 12 2020 | CUE | Cue Biopharma, Inc ... | Millar Kerri-Ann | VP-Finance | Option Exercise | A | 16.26 | 30,000 | 487,800 | 30,000 | |
Feb 12 2020 | CUE | Cue Biopharma, Inc ... | Suri Anish | President and CSO | Option Exercise | A | 16.26 | 65,000 | 1,056,900 | 65,000 | |
Feb 12 2020 | CUE | Cue Biopharma, Inc ... | Suri Anish | President and CSO | Option Exercise | A | 16.26 | 65,000 | 1,056,900 | 65,000 | |
Jan 06 2020 | CUE | Cue Biopharma, Inc ... | Simon Barry J. | Director | Option Exercise | A | 16.31 | 9,600 | 156,576 | 9,600 | |
Jan 06 2020 | CUE | Cue Biopharma, Inc ... | Morich Frank | Director | Option Exercise | A | 16.31 | 8,000 | 130,480 | 8,000 | |
Jan 06 2020 | CUE | Cue Biopharma, Inc ... | MCKNIGHT STEVEN L | Director | Option Exercise | A | 16.31 | 8,000 | 130,480 | 8,000 | |
Jan 06 2020 | CUE | Cue Biopharma, Inc ... | DRISCOLL FREDERICK W | Director | Option Exercise | A | 16.31 | 8,000 | 130,480 | 8,000 | |
Jan 06 2020 | CUE | Cue Biopharma, Inc ... | Fletcher Aaron G.L. | Director | Option Exercise | A | 16.31 | 8,000 | 130,480 | 8,000 | |
Dec 31 2019 | CUE | Cue Biopharma, Inc ... | MARLETT CHRISTOPHER A | Director | Sell | S | 15.71 | 9,000 | 141,390 | 0 | 9 K to 0 (-100.00 %) |
Dec 31 2019 | CUE | Cue Biopharma, Inc ... | MARLETT CHRISTOPHER A | Director | Sell | S | 15.77 | 6,700 | 105,659 | 768,503 | 775.2 K to 768.5 K (-0.86 %) |
Dec 31 2019 | CUE | Cue Biopharma, Inc ... | MARLETT CHRISTOPHER A | Director | Sell | S | 17.24 | 9,000 | 155,160 | 775,203 | 784.2 K to 775.2 K (-1.15 %) |
Dec 27 2019 | CUE | Cue Biopharma, Inc ... | MARLETT CHRISTOPHER A | Director | Sell | S | 17.53 | 19,647 | 344,412 | 784,203 | 803.9 K to 784.2 K (-2.44 %) |
Dec 27 2019 | CUE | Cue Biopharma, Inc ... | MARLETT CHRISTOPHER A | Director | Sell | S | 16.82 | 17,000 | 285,940 | 803,850 | 820.9 K to 803.9 K (-2.07 %) |
Dec 19 2019 | CUE | Cue Biopharma, Inc ... | MARLETT CHRISTOPHER A | Director | Sell | S | 17.00 | 4,000 | 68,000 | 820,850 | 824.9 K to 820.9 K (-0.48 %) |
Dec 19 2019 | CUE | Cue Biopharma, Inc ... | MARLETT CHRISTOPHER A | Director | Sell | S | 15.73 | 20,732 | 326,114 | 824,850 | 845.6 K to 824.9 K (-2.45 %) |
Dec 19 2019 | CUE | Cue Biopharma, Inc ... | MARLETT CHRISTOPHER A | Director | Buy | J | 0.00 | 755,980 | 0 | 845,582 | 89.6 K to 845.6 K (+843.71 %) |
Dec 19 2019 | CUE | Cue Biopharma, Inc ... | MARLETT CHRISTOPHER A | Director | Sell | J | 0.00 | 1,007,973 | 0 | 0 | 1 M to 0 (-100.00 %) |
Nov 04 2019 | CUE | Cue Biopharma, Inc ... | Suri Anish | President and CSO | Option Exercise | M | 0.00 | 33,333 | 0 | 66,667 | |
Nov 04 2019 | CUE | Cue Biopharma, Inc ... | Suri Anish | President and CSO | Payment of Exercise | F | 8.63 | 12,087 | 104,311 | 23,246 | 35.3 K to 23.2 K (-34.21 %) |
Nov 04 2019 | CUE | Cue Biopharma, Inc ... | Suri Anish | President and CSO | Buy | M | 0.00 | 33,333 | 0 | 35,333 | 2 K to 35.3 K (+1,666.65 %) |
Oct 07 2019 | CUE | Cue Biopharma, Inc ... | Fletcher Aaron G.L. | Director | Option Exercise | A | 7.53 | 50,000 | 376,500 | 50,000 | |
Oct 07 2019 | CUE | Cue Biopharma, Inc ... | Suri Anish | President and CSO | Option Exercise | A | 0.00 | 100,000 | 0 | 0 | |
Oct 07 2019 | CUE | Cue Biopharma, Inc ... | Suri Anish | President and CSO | Option Exercise | A | 7.53 | 400,000 | 3,012,000 | 400,000 | |
Jun 25 2019 | CUE | Cue Biopharma, Inc ... | PASSERI DANIEL R | CEO and President | Buy | P | 7.26 | 1,377 | 9,997 | 51,977 | 50.6 K to 52 K (+2.72 %) |
Jun 10 2019 | CUE | Cue Biopharma, Inc ... | Sandercock Colin | SVP, General Counse ... | Buy | P | 7.93 | 14,938 | 118,458 | 16,938 | 2 K to 16.9 K (+746.90 %) |
Jun 10 2019 | CUE | Cue Biopharma, Inc ... | Sandercock Colin | SVP, General Counse ... | Buy | P | 7.10 | 2,000 | 14,200 | 2,000 | 0 to 2 K |
Jun 07 2019 | CUE | Cue Biopharma, Inc ... | PASSERI DANIEL R | CEO and President | Buy | P | 6.90 | 3,000 | 20,700 | 50,600 | 47.6 K to 50.6 K (+6.30 %) |
Mar 08 2019 | CUE | Cue Biopharma, Inc ... | PASSERI DANIEL R | CEO and President | Option Exercise | A | 11.54 | 100,000 | 1,154,000 | 100,000 | |
Mar 08 2019 | CUE | Cue Biopharma, Inc ... | PASSERI DANIEL R | CEO and President | Option Exercise | A | 6.42 | 125,000 | 802,500 | 125,000 | |
Mar 08 2019 | CUE | Cue Biopharma, Inc ... | Suri Anish | Chief Scientific Of ... | Option Exercise | A | 11.54 | 100,000 | 1,154,000 | 100,000 | |
Mar 08 2019 | CUE | Cue Biopharma, Inc ... | Suri Anish | Chief Scientific Of ... | Option Exercise | A | 6.42 | 150,000 | 963,000 | 150,000 | |
Mar 08 2019 | CUE | Cue Biopharma, Inc ... | Mancilla Bethany | SVP and Chief Busin ... | Option Exercise | A | 9.54 | 100,000 | 954,000 | 100,000 | |
Mar 08 2019 | CUE | Cue Biopharma, Inc ... | Mancilla Bethany | SVP and Chief Busin ... | Option Exercise | A | 6.42 | 65,000 | 417,300 | 65,000 | |
Mar 08 2019 | CUE | Cue Biopharma, Inc ... | Sandercock Colin | SVP, General Counse ... | Option Exercise | A | 7.50 | 100,000 | 750,000 | 100,000 | |
Mar 08 2019 | CUE | Cue Biopharma, Inc ... | Sandercock Colin | SVP, General Counse ... | Option Exercise | A | 6.42 | 50,000 | 321,000 | 50,000 | |
Mar 08 2019 | CUE | Cue Biopharma, Inc ... | Millar Kerri-Ann | VP-Finance | Option Exercise | A | 6.42 | 30,000 | 192,600 | 30,000 | |
Jan 28 2019 | CUE | Cue Biopharma, Inc ... | Gray Cameron | Director | Option Exercise | J | 9.38 | 192,495 | 1,804,641 | 192,495 | |
Jan 28 2019 | CUE | Cue Biopharma, Inc ... | Gray Cameron | Director | Option Exercise | J | 9.38 | 192,495 | 1,804,641 | 192,495 | |
Jan 28 2019 | CUE | Cue Biopharma, Inc ... | MARLETT CHRISTOPHER A | Director | Option Exercise | J | 9.38 | 416,656 | 3,906,150 | 416,656 | |
Jan 28 2019 | CUE | Cue Biopharma, Inc ... | MARLETT CHRISTOPHER A | Director | Option Exercise | J | 9.38 | 416,656 | 3,906,150 | 416,656 | |
Jan 04 2019 | CUE | Cue Biopharma, Inc ... | DIGIANDOMENICO ANTHONY | Director | Buy | P | 4.81 | 10,000 | 48,100 | 30,000 | 20 K to 30 K (+50.00 %) |
Jan 02 2019 | CUE | Cue Biopharma, Inc ... | MARLETT CHRISTOPHER A | Director | Buy | P | 4.64 | 18,521 | 85,937 | 89,602 | 71.1 K to 89.6 K (+26.06 %) |
Dec 28 2018 | CUE | Cue Biopharma, Inc ... | DIGIANDOMENICO ANTHONY | Director | Buy | P | 4.77 | 20,000 | 95,400 | 50,000 | 30 K to 50 K (+66.67 %) |
Dec 28 2018 | CUE | Cue Biopharma, Inc ... | DIGIANDOMENICO ANTHONY | Director | Buy | P | 4.77 | 20,000 | 95,400 | 50,000 | 30 K to 50 K (+66.67 %) |
Dec 27 2018 | CUE | Cue Biopharma, Inc ... | MARLETT CHRISTOPHER A | Director | Buy | P | 4.29 | 19,647 | 84,286 | 71,081 | 51.4 K to 71.1 K (+38.20 %) |
Dec 26 2018 | CUE | Cue Biopharma, Inc ... | Suri Anish | Chief Scientific Of ... | Buy | P | 4.37 | 2,000 | 8,740 | 2,000 | 0 to 2 K |
Dec 26 2018 | CUE | Cue Biopharma, Inc ... | MARLETT CHRISTOPHER A | Director | Buy | P | 4.53 | 17,200 | 77,916 | 51,434 | 34.2 K to 51.4 K (+50.24 %) |
Dec 26 2018 | CUE | Cue Biopharma, Inc ... | DIGIANDOMENICO ANTHONY | Director | Buy | P | 4.49 | 10,000 | 44,900 | 20,000 | 10 K to 20 K (+100.00 %) |
Dec 21 2018 | CUE | Cue Biopharma, Inc ... | MARLETT CHRISTOPHER A | Director | Buy | P | 4.74 | 9,438 | 44,736 | 34,234 | 24.8 K to 34.2 K (+38.06 %) |
Dec 20 2018 | CUE | Cue Biopharma, Inc ... | MARLETT CHRISTOPHER A | Director | Buy | P | 5.00 | 400 | 2,000 | 24,796 | 24.4 K to 24.8 K (+1.64 %) |
Dec 19 2018 | CUE | Cue Biopharma, Inc ... | MARLETT CHRISTOPHER A | Director | Buy | P | 5.20 | 3,664 | 19,053 | 24,396 | 20.7 K to 24.4 K (+17.67 %) |
Dec 18 2018 | CUE | Cue Biopharma, Inc ... | DIGIANDOMENICO ANTHONY | Director | Buy | P | 5.48 | 10,000 | 54,800 | 10,000 | 0 to 10 K |
Dec 17 2018 | CUE | Cue Biopharma, Inc ... | MARLETT CHRISTOPHER A | Director | Buy | P | 5.06 | 10,000 | 50,600 | 20,732 | 10.7 K to 20.7 K (+93.18 %) |
Dec 13 2018 | CUE | Cue Biopharma, Inc ... | MARLETT CHRISTOPHER A | Director | Buy | P | 5.07 | 3,189 | 16,168 | 10,732 | 7.5 K to 10.7 K (+42.28 %) |
Dec 13 2018 | CUE | Cue Biopharma, Inc ... | MARLETT CHRISTOPHER A | Director | Buy | P | 5.09 | 9,000 | 45,810 | 9,000 | 0 to 9 K |
Dec 12 2018 | CUE | Cue Biopharma, Inc ... | MARLETT CHRISTOPHER A | Director | Buy | P | 4.86 | 7,543 | 36,659 | 7,543 | 0 to 7.5 K |
Aug 29 2018 | CUE | Cue Biopharma, Inc ... | Millar Kerri-Ann | VP-Finance | Buy | P | 8.48 | 1,000 | 8,480 | 1,000 | 0 to 1,000 |
Aug 20 2018 | CUE | Cue Biopharma, Inc ... | PASSERI DANIEL R | CEO and President | Buy | P | 8.09 | 6,000 | 48,510 | 47,600 | 41.6 K to 47.6 K (+14.42 %) |
Aug 16 2018 | CUE | Cue Biopharma, Inc ... | Suri Anish | Chief Scientific Of ... | Option Exercise | A | 8.26 | 20,000 | 165,200 | 20,000 | |
Aug 02 2018 | CUE | Cue Biopharma, Inc ... | Mancilla Bethany | SVP and Chief Busin ... | Option Exercise | A | 9.54 | 250,000 | 2,385,000 | 250,000 | |
Aug 02 2018 | CUE | Cue Biopharma, Inc ... | Morich Frank | Director | Option Exercise | A | 9.06 | 50,000 | 453,000 | 50,000 | |
Jul 25 2018 | CUE | Cue Biopharma, Inc ... | Millar Kerri-Ann | VP-Finance | Option Exercise | A | 11.54 | 50,000 | 577,000 | 50,000 |